Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Aug. 5, 2013

View Archived Issues

Chinese regulations could prove to be a boon to exporters

New regulations introduced in July in China, could raise costs for domestic device manufacturers but may prove to be a boon for importers. Read More

Mitek Sports launches new Healix Knotless Anchor

NewCo on the Go: Optimum TAV achieves pre-clinical milestone

Washington roundup: GAO decries self-referral for IMRT; docs say 'misleading'

New Ventures: Harvard Bioscience to separate from its HART subsidiary

Product News:

Washington roundup II: Cardiologists surprised CMS ready to dump INTERMACS

People in the News:

Financings roundup: Truven Health closeson $372M senior note exchange offer

Deals roundup: ICU Medical rumored to be in talks to sell itself to GTCR

Keeping you up to date on recent developments in neurology